1. 1001TiPA phase II clinical trial of veliparib and topotecan in patients with platinum resistant ovarian cancer. (23rd October 2018) Authors: Wahner Hendrickson, A E; Costello, B; Jewell, A; Kennedy, V; Fleming, G; Corr, B; Taylor, S E; Lea, J; Reid, J; Swisher, E; Satele, D; Allred, J; Lensing, J; Ivy, S P; Erlichman, C; Adjei, A A; Kaufmann, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗